Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Yamasa Corp. manufactures and supplies soy sauce and seasonings. It processes and supplies soy sauce, seasonings, sauces, dips, and flavorings. The firm also develops pharmaceuticals and biochemicals. The company was founded in 1645 and is headquartered in Choshi, Japan.

Bukwang Pharmaceutical Co., Ltd. was established on October 17th, 1960 and has since continued to produce excellent medications with the aim of improving global health for the last 55 years. Since Bukwang was listed in the Korea Stock Exchange in 1988, Bukwang is proud to have kept a healthy financial status and stable track record that earned trust from its employees and shareholders. Bukwang’s operating profit is at the top of the rank in the industry, nearing 20% as of financial year 2014. Bukwang’s armamentarium consists of more than 100 products in various therapeutic areas: liver disease treatments such as Levovir and Legalon, diabetic complication products such as Dexid and Thioctacid, CNS disorder drugs including Lonasen, Ixel and Orfil, and respiratory disease treatments such as Azeptin and Asima. Bukwang continues to grow its original drug business through consistent focus on new drug development.

Toyo Kohan Co., Ltd. engages in the manufacture and sale of of tinplate, sheet metals, and different types of surface-treated steel sheets as well as a variety of functional materials. It operates through the following segments: Steel Sheet, Functional Materials, and Machinery. The Steel Sheet segment offers functional films for containers, steel plates, and processed steel sheets used as material for electrical and electronic parts, for vehicles, and for external cladding and construction. The Functional Material segment deals with aluminum substrate for magnetic disks and optical functional films. The Machinery segment handles automotive press die and other kinds of die, steel strip for packing materials, machinery instruments, and hard alloys. The company was founded on April 11, 1934 and is headquartered in Tokyo, Japan.

Applied Biology, Inc. develops drugs and medical devices for the treatment of hair disorders. The firm specializes on a topically applied prophylactic treatment for chemotherapy induced alopecia; a novel diagnostic device that can aid dermatologists in identifying non-responders to topical minoxidil; an adjuvant therapy for non-responders to topical minoxidil; and a novel therapy for female pattern hair loss. It offers product conceptualization and design, and regulatory and clinical studies services. The company was founded in 2002 and is headquartered in Irvine, CA.

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Originating as ConjuChem Biotechnologies Inc. of Montreal, Quebec, Canada - ConjuChem, LLC, is now a privately held Los Angeles, CA-based biotechnology company, dedicated to the discovery of novel therapeutics with an initial focus on diabetes. ConjuChem is currently managing several research programs in-house and has one product in clinical development. They are focused on discovering and developing new drugs based on their novel technology platforms called Drug Affinity Complex (DAC™) and Preformed Conjugate-Drug Affinity Complex (PC-DAC™). When applied to a compound, DAC™ or PC-DAC™ can create a new drug with similar therapeutic activity but a significantly longer duration of activity in the body. One of the greatest opportunities for the DAC™ and PC-DAC™ technology from ConjuChem is its potential to enhance the therapeutic activity of peptides by increasing the half-life and efficacy, while improving tolerability. Specifically, peptides generally have short durations of vivo activity, which significantly limits their potential as commercially viable therapeutic products. The DAC™ and PC-DAC™ technology platforms have broad applicability in several targeted indications. They believe there are many attractive potential targets for the constructs being built from these technology platforms. ConjuChem routinely evaluates partnership agreements with other biopharmaceutical firms for research collaborations and licensing agreements while also assessing which programs They may consider developing and commercializing on its own.

Manufactures and sells pulp and cellulose pulp products

ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals. Its peptide products are used to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. ConjuChem Biotechnologies is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. The company was founded on August 25, 2009 and is headquartered in Montréal, Canada.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Hawon Pharmaceutical Co. Ltd. manufactures and wholesales pharmaceuticals. The firm's products include provides antispasmodics, fungicides, cerebral activators, muscle relaxants, and oral anti-diabetic agents. The company was founded in April 1981 and is headquartered in Seoul, South Korea.

Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Sichuan Guangsheng Investment Management Co., Ltd., established on 2007-01-19, Business scope includes project investment,Investment Advisory(Does not include finance,futures,securities),Investment Management Services,Enterprise Investment Planning,Business Information Consulting Service;Sales:electronics(car not included),building materials(No paint),Daily necessities,Chemical Products(Does not contain dangerous goods),communication equipment(Does not include radio transmitters),Computer hardware and software,Instrumentation,office furniture,office equipment(Color copier not included),construction machinery,Air Conditioning Equipment Ventilation Equipment,fire safety equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Hunan Fuxing Feige Pharmaceutical Co., Ltd., established on 1998-12-24, Business scope includes licensed projects:Pharmaceutical commissioned production;pharmaceutical production;Drug Wholesale;Drug retail;Drug internet information service;wine production;liquor business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:housing lease;Non-residential real estate leases;Machinery and Equipment Leasing;Land use right lease;rental service(Licensed rental services not included);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Part of Bayer AG, Bayer New Zealand Ltd. is an of New Zealand company. The firm develops and manufactures and wholesales molecules for human and animal sector.

Farmitalia Carlo Erba